Posted by Michael Wonder on 30 Jun 2023
Moderna initiates rolling submission to Health Canada for updated COVID-19 vaccine
29 June 2023 - Health Canada submission follows international recommendations to develop monovalent XBB.1.5 COVID-19 vaccines.
Moderna today announced that it has initiated the filing of a rolling new drug submission to Health Canada for its updated monovalent COVID-19 vaccine, Spikevax XBB.1.5 (mRNA1273.815) targeting the omicron sub-variant XBB.1.5 of SARS-CoV-2.
